BEXSERO CPT Vaccine Code: 90620

Vaccine & Product Overview

HCPCS Descriptor Meningococcal recombinant protein and outer membrane vesicle vaccine, serogroup B (MenB-4C), for intramuscular use

Manufacturer Glaxo Smithkline Pharmaceuticals

Route of Administration Intramuscular

Generic Status Single-Source; Branded

Dosage Type Single-Dose

Dosage Form Injection, Suspension

About BEXSERO

Bexsero is a medication aligned to the HCPCS CPT Drug Code: 90620 for billing, pricing, and reimbursement purposes in the United States. This Vaccine medication is administered via the intramuscular route and manufactured by Glaxo Smithkline Pharmaceuticals.

Manufacturers, reach out to us to add more information.

NDC Code Information

1 NDC package is crosswalked to 90620. Package detail is available to logged-in subscribers.

NDC Code	Drug	Manufacturer	Billing Units / Pkg	Package Size
•••••-••••-•• Log in to view	BEXSERO

Login to view 1 NDC package View pricing, complete NDC-to-HCPCS alignments, and package details.

Login →

BEXSERO Pricing & Reimbursement

90620 Private Payer Reimbursement

$269.55 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →

BEXSERO Vaccine Administration Codes

CPT Code	Description
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), one vaccine (single or combination vaccine/toxoid)
90472	Immunization administration (each additional vaccine or toxoid), when performed in conjunction with primary procedure.

BEXSERO Medically Unlikely Edits (MUE)

The most billing units of 90620 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 1 dose.

Practitioner Office & Hospital Outpatient

1 unit / day

Same limit in both settings

MAI 2 · Date of Service Edit: Policy. Absolute per-day limit set by policy or regulation; units above it are not payable, and denials are not appealable on medical-necessity grounds. See all MUE limits →

BEXSERO Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Invasive meningococcal disease (Neisseria meningitidis serogroup B)

Frequently Asked Questions

Is there an available Bexsero billing and coding guide?

Billing and coding information for BEXSERO can be found through GSK. Visit Here →

Are there any available Bexsero patient assistance programs?

BEXSERO patient assistance information can be found through GSK. Visit Here →

Where can I find Bexsero prescribing information?

BEXSERO prescribing information can be found at the link below: Visit Here →

Where can I find Bexsero side effect information?

Information regarding BEXSERO's side effects can be found at MedlinePlus Visit Here →

Does billing BEXSERO require JZ/JW wastage modifiers?

CMS does not include BEXSERO (90620) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing 90620. For more information, visit the link below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.